Physical exercise may also be helpful in reducing the risk and/or degree of myopia
doi:10.1016/S0021-9258(18)97085-7
Mozaffarian D, Agarwal M, Aggarwal M, Alexander L, Apovian CM, Bindlish S, et al
Here are the highlights from the large-scale study: The test subjects included 1900 patients, all of whom had body-mass indexes of over 30, meaning they qualified as clinically obese Each participant received either 2.4 mg of semaglutide injected subcutaneously (under the skin) or a placebo The trial lasted over a year At the end of the trial, the patients who received semaglutide experienced a 14.9% loss in excess body weight
From there, your progress is followed closely, with regular check-ins and adjustments based on how your body is responding
People may respond differently to these medications, so doctors often make decisions based on a persons individual health needs and goals